TAKHZYRO INJVLST 150MG/ML PEN 2ML

Active substance
LANADELUMAB
Therapeutical formulation
INJECTIEVLOEISTOF

€ 13,945.25 € 13,945.25 excluding delivery costs.

This drug is fully reimbursed by your health insurance company.

Own risk

€ 13,945.25 € 13,945.25

This is the amount charged to your deductible per piece per package.

Strength
150MG/ML
Supplier
TAKEDA NEDERLAND BV
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
EU number
EU/1/18/1340/010

Variants

Alternatives

See also